Related Experiment Videos
Thalassemia in Bombay: the role of medical genetics in developing countries
B Sangani1, P K Sukumaran, C Mahadik
1Research Laboratories, B.J. Wadia Hospital for Children, Parel, Bombay, India.
Insights
Thalassaemia treatment in Bombay places a heavy burden on families and public health services, especially in developing nations. Improved management, including prenatal diagnosis and parent associations, is crucial for controlling this genetic disorder.
Area of Science:
- Medical Genetics
- Public Health
- Pediatrics
Background:
- Thalassaemia poses a significant and growing demand on public health services.
- In developing countries, the financial burden of thalassaemia treatment is substantial for families, consuming 20-30% of income.
- Social isolation due to ignorance and prejudice affects families with thalassaemic children.
Purpose of the Study:
- To assess the impact of thalassaemia on families and public health services in Bombay.
- To identify challenges in thalassaemia management and prevention.
- To explore strategies for improved thalassaemia control in developing countries.
Main Methods:
- Study of 200 families with thalassaemic children in Bombay.
- Analysis of treatment costs, family burden, and social impact.
- Review of existing management practices and potential interventions.
Main Results:
- Inadequate planning and prevention lead to premature deaths.
- High treatment costs create a significant economic burden on families.
- Prenatal diagnosis is perceived as essential by 90% of couples of reproductive age.
- Parental sterilization was observed in mothers with limited healthy children.
Conclusions:
- Improved treatment, such as day-transfusion services, is cost-effective and improves patient outcomes.
- Parent associations can mobilize community support and raise awareness.
- Screening, genetic counseling, and prenatal diagnosis are vital for cost-effective management and prevention in all countries.
Abstract:
This study of 200 families with thalassaemic children in Bombay showed that these children's treatment and needs place a significant, unavoidable and increasing demand on the public health services. At the same time, owing to the potentially large number of patients and the difficulties of long-term management, the situation is characterized by evasion of the problem, failure of planning, no provisions for prevention, and inadequate treatment leading to premature death among the affected children. The burden on such families is greater in developing than in developed countries because, besides caring for the chronically sick child, their lives are dominated by the high costs of treatment, often amounting to 20-30% of the income for many families. Seven mothers with no healthy children and 27 with only one healthy child had been sterilized; 90% of reproductive-age couples felt that prenatal diagnosis was a necessity. Also, ignorance and prejudice in the community led to social isolation for forty families. The experience in Europe shows that improved treatment is the key step in controlling thalassaemia. A well-organized day-transfusion service is cost-effective, soon restoring the children to health and leading to increased optimism. The formation of associations by parents could mobilize community support for improved treatment and prevention, and increase public awareness of the problem. Thus cost-effective management and prevention through screening, genetic counselling, and prenatal diagnosis are at least as important in the developing as in developed countries.